REGENXBIO
RGNX
#7517
Rank
โ‚น47.51 B
Marketcap
โ‚น718.62
Share price
-4.86%
Change (1 day)
-27.22%
Change (1 year)

Earnings for REGENXBIO (RGNX)

Earnings in 2026 (TTM): -โ‚น12.83 Billion

According to REGENXBIO's latest financial reports the company's current earnings are โ‚น0.15 Billion. In 2025 the company made an earning of -โ‚น14.01 Billion, an increase over its 2024 earnings that were of -โ‚น20.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for REGENXBIO from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น12.83 Billion-8.4%
2025 -โ‚น14.01 Billion-30.58%
2024 -โ‚น20.18 Billion-16.49%
2023 -โ‚น24.16 Billion-0.14%
2022 -โ‚น24.19 Billion-253.5%
2021 โ‚น15.75 B-259.29%
2020 -โ‚น9.9 Billion-29.42%
2019 -โ‚น14.02 Billion-269.12%
2018 โ‚น8.28 B-216.1%
2017 -โ‚น7.14 Billion19.69%
2016 -โ‚น5.97 Billion178.03%
2015 -โ‚น2.15 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น14.69 Billion 12.34%๐Ÿ‡บ๐Ÿ‡ธ USA